Annual CFF
$31.17 M
-$7.04 M-18.42%
December 31, 2023
Summary
- As of February 8, 2025, PAVM annual cash flow from financing activities is $31.17 million, with the most recent change of -$7.04 million (-18.42%) on December 31, 2023.
- During the last 3 years, PAVM annual CFF has fallen by -$1.83 million (-5.55%).
- PAVM annual CFF is now -70.11% below its all-time high of $104.31 million, reached on December 31, 2021.
Performance
PAVM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$284.00 K
-$11.34 M-97.56%
September 30, 2024
Summary
- As of February 8, 2025, PAVM quarterly cash flow from financing activities is $284.00 thousand, with the most recent change of -$11.34 million (-97.56%) on September 30, 2024.
- Over the past year, PAVM quarterly CFF has dropped by -$68.00 thousand (-19.32%).
- PAVM quarterly CFF is now -99.53% below its all-time high of $60.07 million, reached on December 31, 2021.
Performance
PAVM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$36.24 M
-$68.00 K-0.19%
September 30, 2024
Summary
- As of February 8, 2025, PAVM TTM cash flow from financing activities is $36.24 million, with the most recent change of -$68.00 thousand (-0.19%) on September 30, 2024.
- Over the past year, PAVM TTM CFF has increased by +$10.28 million (+39.58%).
- PAVM TTM CFF is now -65.26% below its all-time high of $104.31 million, reached on December 31, 2021.
Performance
PAVM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PAVM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | -19.3% | +39.6% |
| 3 y3 years | -5.5% | -98.9% | -58.9% |
| 5 y5 years | +101.1% | -98.9% | -58.9% |
PAVM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.1% | at low | -99.5% | +255.0% | -65.3% | +43.3% |
| 5 y | 5-year | -70.1% | +173.9% | -99.5% | +255.0% | -65.3% | +218.4% |
| alltime | all time | -70.1% | +2546.7% | -99.5% | +278.6% | -65.3% | >+9999.0% |
PAVmed Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $284.00 K(-97.6%) | $36.24 M(-0.2%) |
| Jun 2024 | - | $11.62 M(-39.0%) | $36.31 M(+43.5%) |
| Mar 2024 | - | $19.05 M(+260.2%) | $25.30 M(-18.8%) |
| Dec 2023 | $31.17 M(-18.4%) | $5.29 M(+1402.3%) | $31.17 M(+20.1%) |
| Sep 2023 | - | $352.00 K(-42.2%) | $25.96 M(-31.5%) |
| Jun 2023 | - | $609.00 K(-97.6%) | $37.90 M(-39.7%) |
| Mar 2023 | - | $24.92 M(>+9900.0%) | $62.82 M(+64.4%) |
| Dec 2022 | $38.21 M(-63.4%) | $80.00 K(-99.3%) | $38.21 M(-61.1%) |
| Sep 2022 | - | $12.29 M(-51.9%) | $98.20 M(+11.3%) |
| Jun 2022 | - | $25.53 M(+7977.8%) | $88.20 M(+37.5%) |
| Mar 2022 | - | $316.00 K(-99.5%) | $64.13 M(-38.5%) |
| Dec 2021 | $104.31 M(+216.0%) | $60.07 M(+2530.1%) | $104.31 M(+74.0%) |
| Sep 2021 | - | $2.28 M(+56.4%) | $59.94 M(-7.4%) |
| Jun 2021 | - | $1.46 M(-96.4%) | $64.71 M(-3.7%) |
| Mar 2021 | - | $40.49 M(+157.9%) | $67.19 M(+103.6%) |
| Dec 2020 | $33.01 M(+190.0%) | $15.70 M(+122.5%) | $33.01 M(+40.3%) |
| Sep 2020 | - | $7.06 M(+78.8%) | $23.52 M(+42.3%) |
| Jun 2020 | - | $3.95 M(-37.4%) | $16.53 M(-7.4%) |
| Mar 2020 | - | $6.30 M(+1.5%) | $17.84 M(+56.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $11.38 M(-26.6%) | $6.21 M(+9174.6%) | $11.38 M(+58.7%) |
| Sep 2019 | - | $67.00 K(-98.7%) | $7.17 M(+1.0%) |
| Jun 2019 | - | $5.26 M(-3407.5%) | $7.10 M(-35.8%) |
| Mar 2019 | - | -$159.00 K(-107.9%) | $11.05 M(-28.7%) |
| Dec 2018 | $15.50 M(+105.0%) | $2.00 M(<-9900.0%) | $15.50 M(+14.7%) |
| Sep 2018 | - | -$6200.00(-100.1%) | $13.51 M(-28.6%) |
| Jun 2018 | - | $9.21 M(+114.4%) | $18.92 M(+94.9%) |
| Mar 2018 | - | $4.30 M(>+9900.0%) | $9.71 M(+28.4%) |
| Dec 2017 | $7.56 M(+76.1%) | $10.60 K(-99.8%) | $7.56 M(+0.1%) |
| Sep 2017 | - | $5.40 M(>+9900.0%) | $7.55 M(+251.2%) |
| Jun 2017 | - | $0.00(-100.0%) | $2.15 M(-66.6%) |
| Mar 2017 | - | $2.15 M(>+9900.0%) | $6.45 M(+50.1%) |
| Dec 2016 | $4.30 M(+264.7%) | $0.00(0.0%) | $4.30 M(0.0%) |
| Sep 2016 | - | $0.00(-100.0%) | $4.30 M(-22.0%) |
| Jun 2016 | - | $4.30 M(>+9900.0%) | $5.51 M(+347.7%) |
| Mar 2016 | - | $0.00(0.0%) | $1.23 M(+4.4%) |
| Dec 2015 | $1.18 M | $0.00(-100.0%) | $1.18 M(0.0%) |
| Sep 2015 | - | $1.21 M(+6413.4%) | $1.18 M(-3595.0%) |
| Jun 2015 | - | $18.60 K(-135.6%) | -$33.70 K(-35.6%) |
| Mar 2015 | - | -$52.30 K | -$52.30 K |
FAQ
- What is PAVmed annual cash flow from financing activities?
- What is the all time high annual CFF for PAVmed?
- What is PAVmed annual CFF year-on-year change?
- What is PAVmed quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PAVmed?
- What is PAVmed quarterly CFF year-on-year change?
- What is PAVmed TTM cash flow from financing activities?
- What is the all time high TTM CFF for PAVmed?
- What is PAVmed TTM CFF year-on-year change?
What is PAVmed annual cash flow from financing activities?
The current annual CFF of PAVM is $31.17 M
What is the all time high annual CFF for PAVmed?
PAVmed all-time high annual cash flow from financing activities is $104.31 M
What is PAVmed annual CFF year-on-year change?
Over the past year, PAVM annual cash flow from financing activities has changed by -$7.04 M (-18.42%)
What is PAVmed quarterly cash flow from financing activities?
The current quarterly CFF of PAVM is $284.00 K
What is the all time high quarterly CFF for PAVmed?
PAVmed all-time high quarterly cash flow from financing activities is $60.07 M
What is PAVmed quarterly CFF year-on-year change?
Over the past year, PAVM quarterly cash flow from financing activities has changed by -$68.00 K (-19.32%)
What is PAVmed TTM cash flow from financing activities?
The current TTM CFF of PAVM is $36.24 M
What is the all time high TTM CFF for PAVmed?
PAVmed all-time high TTM cash flow from financing activities is $104.31 M
What is PAVmed TTM CFF year-on-year change?
Over the past year, PAVM TTM cash flow from financing activities has changed by +$10.28 M (+39.58%)